SciClone Settles with the SEC on FCPA Enforcement Action

Title: SciClone Settles with the SEC As SciClone Pharmaceuticals settles with the SEC for FCPA violations committed by a Chinese subsidiary, Tom Fox considers how the finer points of granting favors to government officials merits greater compliance scrutiny.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.